UB 311
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for UB 311, covering 2011-08-23 to 2020-12-17. Get the full timeline:
Most recent: Clinical Trial Update: An Extension Study of V203-AD Study to Evaluate the Safety, Tolerability, Immunogenicity, and Efficacy of UB-311 [Phase 2]